Evidence map›Paper›PMID 29098364›Full record

ArticleCurrent genetics2018

Generation of an arginine-tRNA-adapted Saccharomyces cerevisiae strain for effective heterologous protein expression.

Marcel Noßmann, Jana Pieper, Falk Hillmann, Axel A Brakhage, Thomas Munder

Abstract read
PubMed Publisher
In one paragraph

Article in Current genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Marcel NoßmannDepartment of Medical Engineering and Biotechnology, Ernst-Abbe-Hochschule Jena, University of Applied Sciences, Carl-Zeiss-Promenade 2, 07745, Jena, Germany.
Jana PieperDepartment of Medical Engineering and Biotechnology, Ernst-Abbe-Hochschule Jena, University of Applied Sciences, Carl-Zeiss-Promenade 2, 07745, Jena, Germany.
Falk HillmannJunior Research Group Evolution of Microbial Interactions, Leibniz-Institute for Natural Product Research and Infection Biology-HKI, Beutenbergstr. 11a, 07745, Jena, Germany.
Axel A BrakhageDepartment of Molecular and Applied Microbiology, Leibniz-Institute for Natural Product Research and Infection Biology-Hans Knoell Institute (HKI) and Friedrich Schiller University Jena, Beutenbergstr. 11a, 07745, Jena, Germany.
Thomas MunderDepartment of Medical Engineering and Biotechnology, Ernst-Abbe-Hochschule Jena, University of Applied Sciences, Carl-Zeiss-Promenade 2, 07745, Jena, Germany. Thomas.Munder@eah-jena.de.ORCID http://orcid.org/0000-0002-2557-5869
Carl Zeiss (Germany) · DELeibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) · DE

Funding

Deutsche Forschungsgemeinschaft center/transregio 124 FungiNet (project A1)
6 · The paper itself

Abstract

The tRNA population reflects the codon bias of the organism and affects the translation of heterologous target mRNA molecules. In this study, Saccharomyces cerevisiae strains with modified levels of rare tRNA were engineered, that allowed efficient generation of recombinant proteins with unfavorable codon usage. We established a novel synthetic tRNA expression cassette and verified functional nonsense suppressor tRNA

Indexed as

Aspergillus fumigatusCodonCodon, TerminatorGenes, FungalRecombinant ProteinsRNA, FungalRNA, Transfer, ArgSaccharomyces cerevisiaeTwo-Hybrid System TechniquesCodonCodon, TerminatorRecombinant ProteinsRNA, FungalRNA, Transfer, ArgAspergillus fumigatusCodon usageHeterologous protein expressionSaccharomyces cerevisiaetRNAYeast two-hybrid system

Identifiers

PMID29098364
OpenAlexW2765147493

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.